Pioglitazone
Product Images NDC 53002-2756

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 53002-2756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure diagram of pioglitazone hydrochloride, showing its molecular framework including aromatic rings, thiazolidinedione ring, and hydrochloride salt form.*

FDA Label Image

Figure 1 (Image 2)

A line graph showing mean values over 26 weeks for four groups: placebo, 15 mg, 30 mg, and 45 mg. The x-axis represents weeks from 0 to 26, and the y-axis represents the mean. Each group is displayed by different line styles and colors with a legend identifying them below the graph.*

FDA Label Image

Label Image (Lbl530022756)

Pioglitazone HCl 30mg tablets packaging label from RPK Pharmaceuticals, Inc. This carton contains 30 white round tablets, with dosing instructions to take one tablet daily or as directed. The label includes prescription-only status, storage information, and placeholders for clinic, patient, provider, and dispensing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.